These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5495497)

  • 1. Characterization of the content uniformity plan.
    Sampson CB; Breunig HL; Comer JP; Broadlick DE
    J Pharm Sci; 1970 Nov; 59(11):1653-5. PubMed ID: 5495497
    [No Abstract]   [Full Text] [Related]  

  • 2. Testing for uniformity: sampling plans in pharmacopeias for weight, volume, and content uniformity.
    Pietra V; Setnikar I
    J Pharm Sci; 1970 Apr; 59(4):530-5. PubMed ID: 5440682
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of medication dose uniformity in commonly split tablets.
    Teng J; Song CK; Williams RL; Polli JE
    J Am Pharm Assoc (Wash); 2002; 42(2):195-9. PubMed ID: 11926662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panel discussion: in process control and inspection for quality assurance. 3.
    Brofazi FR
    Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of the analytical error on content uniformity sampling plans.
    Norberg R
    Pharm Acta Helv; 1972; 47(11):710-8. PubMed ID: 4657537
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical controls for drug availability.
    Cook D
    Med Serv J Can; 1967 Mar; 23(3):323-36. PubMed ID: 6056376
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of statistical analysis of blend and dosage unit content uniformity data obtained from the Product Quality Research Institute Blend Uniformity Working Group data-mining effort.
    Boehm G; Clark J; Dietrick J; Foust L; Garcia T; Gavini M; Geoffroy JM; Jimenez P; Mergen G; Muzzio F; Planchard J; Prescott J; Timmermans J; Takiar N; Whiteman D;
    PDA J Pharm Sci Technol; 2004; 58(2):62-74. PubMed ID: 15113072
    [No Abstract]   [Full Text] [Related]  

  • 8. Objective visual evaluation of the relative content of major and minor defects in tablets and capsules.
    Stone JC
    J Pharm Sci; 1970 Sep; 59(9):1364. PubMed ID: 5469814
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progress in the production and control of tablets. X. On the theoretical basis of compressing].
    Malý J
    Cesk Farm; 1968 Feb; 17(2):94-8. PubMed ID: 4871275
    [No Abstract]   [Full Text] [Related]  

  • 10. [A simple method for the determination of the degree of fineness of tablet fragments after disintegration].
    Sanders JC
    Pharm Weekbl; 1969 Jun; 104(24):485-92. PubMed ID: 5791767
    [No Abstract]   [Full Text] [Related]  

  • 11. Tablet splitting: imperfect perhaps, but better than excessive dosing.
    Cohen JS
    J Am Pharm Assoc (Wash); 2002; 42(2):160-2. PubMed ID: 11926659
    [No Abstract]   [Full Text] [Related]  

  • 12. Tablet splitting, education on NABP delegates' minds.
    Am J Health Syst Pharm; 2001 Aug; 58(15):1390, 1394. PubMed ID: 11494782
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of the statistical characteristics of the USP XXI content uniformity sampling plan for tablets].
    Tao QF; Zhong DF; Luo X; Wang X
    Yao Xue Xue Bao; 1987 Mar; 22(3):212-6. PubMed ID: 3661209
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Content uniformity.
    Haynes JD
    J Pharm Sci; 1974 Oct; 63(10):VI. PubMed ID: 4436777
    [No Abstract]   [Full Text] [Related]  

  • 15. Weight variability of pharmacist-dispensed split tablets.
    Rosenberg JM; Nathan JP; Plakogiannis F
    J Am Pharm Assoc (Wash); 2002; 42(2):200-5. PubMed ID: 11926663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uniformity of content requirements for tablets and capsules.
    Kendall CE; Low GK; Hailey DM
    J Pharm Pharmacol; 1981 Apr; 33(4):197-202. PubMed ID: 6115899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on flow properties of powders. IV. Flow properties of tablet granulations and the uniformity of tablet content.
    Kristensen HG
    Dan Tidsskr Farm; 1969; 43(9):213-9. PubMed ID: 5371697
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of drug proportion and mixing time on the content uniformity of a low dose drug in a high shear mixer.
    Kornchankul W; Hamed E; Parikh NH; Sakr A
    Pharmazie; 2002 Jan; 57(1):49-53. PubMed ID: 11836931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tablet splitting: much ado about nothing?
    Navarro RP
    J Manag Care Pharm; 2009 Apr; 15(3):272-4. PubMed ID: 19326958
    [No Abstract]   [Full Text] [Related]  

  • 20. Is propranolol compounding from tablet safe for pediatric use? Results from an experimental test.
    Casiraghi A; Musazzi UM; Franceschini I; Berti I; Paragò V; Cardosi L; Minghetti P
    Minerva Pediatr; 2014 Oct; 66(5):355-62. PubMed ID: 25253183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.